BEAM (BEAM) is trading at $0.001492 down 2.79% over the past 24 hours. Its Galaxy Score is 35.7, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 11K engagements and 121 posts with 91% positive social sentiment.
AI summary: BEAM is a biotech-themed cryptocurrency token associated with gene-editing equities like Beam Therapeutics, trading as a Layer 1 asset on Ethereum, BNB Chain, and Base. BEAM's +14.55% weekly gain and 158% volume surge reflect fresh catalysts — Moderna's Phase 3 success, ARK's gene-editing spotlight, and a viral commercial-stage hiring post — driving speculative inflows. However, the -4.83% 24-hour dip near $0.00153 shows licensing caps and macro volatility capping upside, so 92% bullish sentiment isn't converting into sustained price appreciation.